Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Bernia

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAMA Dermatology|April 28, 2021
Stewart-Treves SyndromeEduardo Bernia, Elisa Rios-Viñuela, Celia Requena
JAMA Dermatology|July 28, 2021
Erythematoedematous and Sclerotic Plaques in a Man Receiving Systemic ChemotherapyMar Ramírez-Lluch, Eduardo Bernia, Onofre Sanmartín-Jiménez
International Journal of Dermatology|June 5, 2020
A unilateral zosteriform cutaneous eruption on the lower extremityElisa Ríos-Viñuela, Eduardo Bernia, Adrián Diago, et al.
Journal of Cutaneous Pathology|May 13, 2020
Cutaneous intralymphatic histiocytosis associated with breast and orthopedic surgeryElisa Ríos-Viñuela, Eduardo Bernia, Adrián Diago, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|January 17, 2021
Usefulness of ultrasound in dermatofibrosarcoma protuberans and correlation with histopathological findings: A series of 30 casesAdrian Diago, Beatriz Llombart, Carlos Serra-Guillen, et al.
Acta Dermato-Venereologica|March 18, 2021
Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance RevisitedElisa Ríos-Viñuela, Eduardo Bernia, Tomás Toledo-Pastrana, et al.
Dermatology and Therapy|February 24, 2026
Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter CohortFrancisco Javier Melgosa Ramos, Santiago Guillén Climent, Marta Galarreta Pascual, et al.
Anais Brasileiros De Dermatologia|April 22, 2025
Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective studyFrancisco Javier Melgosa Ramos, Carlos Abril Pérez, Santiago Guillén Climent, et al.
International Journal of Dermatology|April 16, 2025
Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter StudyFrancisco Javier Melgosa Ramos, Lorena Vila Cobreros, Marta Galarreta Pascual, et al.
Dermatology (Basel, Switzerland)|May 31, 2023
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS StudyVerónica Ruiz-Salas, Sebastian Podlipnik, Alejandra Sandoval-Clavijo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA Dermatology|April 28, 2021
Stewart-Treves SyndromeEduardo Bernia, Elisa Rios-Viñuela, Celia Requena
JAMA Dermatology|July 28, 2021
Erythematoedematous and Sclerotic Plaques in a Man Receiving Systemic ChemotherapyMar Ramírez-Lluch, Eduardo Bernia, Onofre Sanmartín-Jiménez
International Journal of Dermatology|June 5, 2020
A unilateral zosteriform cutaneous eruption on the lower extremityElisa Ríos-Viñuela, Eduardo Bernia, Adrián Diago, et al.
Journal of Cutaneous Pathology|May 13, 2020
Cutaneous intralymphatic histiocytosis associated with breast and orthopedic surgeryElisa Ríos-Viñuela, Eduardo Bernia, Adrián Diago, et al.
Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [And] International Society for Digital Imaging of Skin (ISDIS) [And] International Society for Skin Imaging (ISSI)|January 17, 2021
Usefulness of ultrasound in dermatofibrosarcoma protuberans and correlation with histopathological findings: A series of 30 casesAdrian Diago, Beatriz Llombart, Carlos Serra-Guillen, et al.
Acta Dermato-Venereologica|March 18, 2021
Localized Injection-site Toxic Erythema of Chemotherapy: An Under-recognized Acquaintance RevisitedElisa Ríos-Viñuela, Eduardo Bernia, Tomás Toledo-Pastrana, et al.
Dermatology and Therapy|February 24, 2026
Minimal Disease Activity as a Therapeutic Goal in Atopic Dermatitis: Predictive Factors of Sustainability in a Multicenter CohortFrancisco Javier Melgosa Ramos, Santiago Guillén Climent, Marta Galarreta Pascual, et al.
Anais Brasileiros De Dermatologia|April 22, 2025
Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective studyFrancisco Javier Melgosa Ramos, Carlos Abril Pérez, Santiago Guillén Climent, et al.
International Journal of Dermatology|April 16, 2025
Effectiveness and Safety of Upadacitinib in Adults Older Than 50 Years With Moderate-To-Severe Atopic Dermatitis: A Multicenter StudyFrancisco Javier Melgosa Ramos, Lorena Vila Cobreros, Marta Galarreta Pascual, et al.
Dermatology (Basel, Switzerland)|May 31, 2023
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS StudyVerónica Ruiz-Salas, Sebastian Podlipnik, Alejandra Sandoval-Clavijo, et al.
Pageof 1